OncoCyte Corporation (OCX)
NASDAQ: OCX · IEX Real-Time Price · USD
3.210
+0.090 (2.88%)
At close: Jul 19, 2024, 4:00 PM
3.130
-0.080 (-2.49%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
OncoCyte Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for OncoCyte stock have an average target of 4.06, with a low estimate of 3.00 and a high estimate of 5.00. The average target predicts an increase of 26.48% from the current stock price of 3.21.
Analyst Consensus: Buy
* Price targets were last updated on May 16, 2024.
Analyst Ratings
The average analyst rating for OncoCyte stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | +32.40% | May 16, 2024 |
| Needham | Needham | Strong Buy Maintains $3.6 → $4.25 | Strong Buy | Maintains | $3.6 → $4.25 | +32.40% | Apr 24, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +24.61% | Apr 17, 2024 |
| Benchmark | Benchmark | Buy Reiterates $5 | Buy | Reiterates | $5 | +55.76% | Apr 15, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $3.5 → $3 | Hold | Maintains | $3.5 → $3 | -6.54% | Nov 13, 2023 |
Financial Forecast
Revenue This Year
1.52M
from 1.50M
Increased by 1.26%
Revenue Next Year
3.98M
from 1.52M
Increased by 161.63%
EPS This Year
-2.79
from -3.75
EPS Next Year
-2.13
from -2.79
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.9M | 6.0M | 11.9M |
| Avg | 1.5M | 4.0M | 11.4M |
| Low | 1.2M | 2.1M | 11.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 25.7% | 293.2% | 198.0% |
| Avg | 1.3% | 161.6% | 186.6% |
| Low | -20.9% | 40.7% | 178.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.56 | -1.71 | -1.49 |
| Avg | -2.79 | -2.13 | -1.43 |
| Low | -3.03 | -2.53 | -1.39 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.